{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:06:50Z","timestamp":1794049610351,"version":"4.8.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41386-021-01098-z","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T21:45:15Z","timestamp":1627681515000},"page":"2101-2111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial"],"prefix":"10.1038","volume":"46","author":[{"given":"Florence","family":"Morissette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Mongeau-P\u00e9russe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Rizkallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam\u00e9la","family":"Th\u00e9bault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Brissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Dubreucq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2859-2100","authenticated-orcid":false,"given":"Emmanuel","family":"Stip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Cailhier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-508X","authenticated-orcid":false,"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"1098_CR1","unstructured":"United Nations Office on Drugs and Crime. World drug report 2019. Vienna, Austria: United Nations Publications; 2019. Sales No. E.19.XI.8."},{"key":"1098_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/00952990.2013.772618","volume":"39","author":"L Florez-Salamanca","year":"2013","unstructured":"Florez-Salamanca L, Secades-Villa R, Hasin DS, Cottler L, Wang S, Grant BF, et al. Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Drug Alcohol Abus. 2013;39:168\u201379. https:\/\/doi.org\/10.3109\/00952990.2013.772618.","journal-title":"Am J Drug Alcohol Abus"},{"key":"1098_CR3","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/s0140-6736(19)32230-5","volume":"394","author":"M Farrell","year":"2019","unstructured":"Farrell M, Martin NK, Stockings E, B\u00f3rquez A, Cepeda JA, Degenhardt L, et al. Responding to global stimulant use: challenges and opportunities. Lancet 2019;394:1652\u201367. https:\/\/doi.org\/10.1016\/s0140-6736(19)32230-5.","journal-title":"Lancet"},{"key":"1098_CR4","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3389\/fimmu.2019.02435","volume":"10","author":"A Zaparte","year":"2019","unstructured":"Zaparte A, Schuch JB, Viola TW, Baptista TAS, Beidacki AS, do Prado CH, et al. Cocaine use disorder is associated with changes in Th1\/Th2\/Th17 cytokines and lymphocytes subsets. Front Immunol. 2019;10:2435. https:\/\/doi.org\/10.3389\/fimmu.2019.02435.","journal-title":"Front Immunol"},{"key":"1098_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2013.03.045","volume":"544","author":"JC Narvaez","year":"2013","unstructured":"Narvaez JC, Magalhaes PV, Fries GR, Colpo GD, Czepielewski LS, Vianna P, et al. Peripheral toxicity in crack cocaine use disorders. Neurosci Lett. 2013;544:80\u20134. https:\/\/doi.org\/10.1016\/j.neulet.2013.03.045.","journal-title":"Neurosci Lett"},{"key":"1098_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.drugalcdep.2015.11.024","volume":"158","author":"FP Moreira","year":"2016","unstructured":"Moreira FP, Medeiros JR, Lhullier AC, Souza LD, Jansen K, Portela LV, et al. Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10. Drug Alcohol Depend. 2016;158:181\u20135. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.11.024.","journal-title":"Drug Alcohol Depend"},{"key":"1098_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/hup.1251","volume":"27","author":"HC Fox","year":"2012","unstructured":"Fox HC, D\u2019Sa C, Kimmerling A, Siedlarz KM, Tuit KL, Stowe R, et al. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum Psychopharmacol. 2012;27:156\u201366. https:\/\/doi.org\/10.1002\/hup.1251.","journal-title":"Hum Psychopharmacol"},{"key":"1098_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jpsychires.2014.02.017","volume":"53","author":"ML Levandowski","year":"2014","unstructured":"Levandowski ML, Viola TW, Wearick-Silva LE, Wieck A, Tractenberg SG, Brietzke E, et al. Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal. J Psychiatr Res. 2014;53:180\u20136. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.02.017.","journal-title":"J Psychiatr Res"},{"key":"1098_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40618-014-0091-8","volume":"37","author":"L Manetti","year":"2014","unstructured":"Manetti L, Cavagnini F, Martino E, Ambrogio A. Effects of cocaine on the hypothalamic\u2013pituitary\u2013adrenal axis. J Endocrinol Invest. 2014;37:701\u20138. https:\/\/doi.org\/10.1007\/s40618-014-0091-8.","journal-title":"J Endocrinol Invest"},{"key":"1098_CR10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1210\/jcem.83.3.4654","volume":"83","author":"MB Sholar","year":"1998","unstructured":"Sholar MB, Mendelson JH, Mello NK, Siegel AJ, Kaufman MJ, Levin JM, et al. Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men. J Clin Endocrinol Metab. 1998;83:966\u20138. https:\/\/doi.org\/10.1210\/jcem.83.3.4654.","journal-title":"J Clin Endocrinol Metab"},{"key":"1098_CR11","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.2174\/092986712803988893","volume":"19","author":"I Riezzo","year":"2012","unstructured":"Riezzo I, Fiore C, De Carlo D, Pascale N, Neri M, Turillazzi E, et al. Side effects of cocaine abuse: multiorgan toxicity and pathological consequences. Curr Med Chem. 2012;19:5624\u201346. https:\/\/doi.org\/10.2174\/092986712803988893.","journal-title":"Curr Med Chem"},{"key":"1098_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pharmthera.2013.04.011","volume":"139","author":"JM Loftis","year":"2013","unstructured":"Loftis JM, Huckans M. Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy. Pharm Ther. 2013;139:289\u2013300. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.04.011.","journal-title":"Pharm Ther"},{"key":"1098_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fncel.2015.00279","volume":"9","author":"R Lopez-Pedrajas","year":"2015","unstructured":"Lopez-Pedrajas R, Ramirez-Lamelas DT, Muriach B, Sanchez-Villarejo MV, Almansa I, Vidal-Gil L, et al. Cocaine promotes oxidative stress and microglial-macrophage activation in rat cerebellum. Front Cell Neurosci. 2015;9:279. https:\/\/doi.org\/10.3389\/fncel.2015.00279.","journal-title":"Front Cell Neurosci"},{"key":"1098_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuropharm.2018.03.019","volume":"135","author":"IE Cisneros","year":"2018","unstructured":"Cisneros IE, Erdenizmenli M, Cunningham KA, Paessler S, Dineley KT. Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes. Neuropharmacology 2018;135:431\u201343. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.03.019.","journal-title":"Neuropharmacology"},{"key":"1098_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nrendo.2014.22","volume":"10","author":"M Picard","year":"2014","unstructured":"Picard M, Juster RP, McEwen BS. Mitochondrial allostatic load puts the \u2018gluc\u2019 back in glucocorticoids. Nat Rev Endocrinol. 2014;10:303\u201310. https:\/\/doi.org\/10.1038\/nrendo.2014.22.","journal-title":"Nat Rev Endocrinol"},{"key":"1098_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.mehy.2004.06.028","volume":"64","author":"P Kovacic","year":"2005","unstructured":"Kovacic P. Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Med Hypotheses. 2005;64:350\u20136. https:\/\/doi.org\/10.1016\/j.mehy.2004.06.028.","journal-title":"Med Hypotheses"},{"key":"1098_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/0271678X15616978","volume":"36","author":"RK Sajja","year":"2016","unstructured":"Sajja RK, Rahman S, Cucullo L. Drugs of abuse and blood\u2013brain barrier endothelial dysfunction: a focus on the role of oxidative stress. J Cereb Blood Flow Metab. 2016;36:539\u201354. https:\/\/doi.org\/10.1177\/0271678X15616978.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1098_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11481-007-9091-1","volume":"3","author":"NK Dhillon","year":"2008","unstructured":"Dhillon NK, Peng F, Bokhari S, Callen S, Shin SH, Zhu X, et al. Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2\/CCR2 axis across the blood\u2013brain barrier: implications for HIV-dementia. J Neuroimmune Pharmacol. 2008;3:52\u20136. https:\/\/doi.org\/10.1007\/s11481-007-9091-1.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1098_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fnins.2020.00513","volume":"14","author":"E Pimentel","year":"2020","unstructured":"Pimentel E, Sivalingam K, Doke M, Samikkannu T. Effects of drugs of abuse on the blood\u2013brain barrier: a brief overview. Front Neurosci. 2020;14:513. https:\/\/doi.org\/10.3389\/fnins.2020.00513.","journal-title":"Front Neurosci"},{"key":"1098_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fphar.2012.00121","volume":"3","author":"SM Kousik","year":"2012","unstructured":"Kousik SM, Napier TC, Carvey PM. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol. 2012;3:121. https:\/\/doi.org\/10.3389\/fphar.2012.00121.","journal-title":"Front Pharmacol"},{"key":"1098_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12640-012-9334-7","volume":"23","author":"KH Clark","year":"2013","unstructured":"Clark KH, Wiley CA, Bradberry CW. Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection. Neurotox Res. 2013;23:174\u201388. https:\/\/doi.org\/10.1007\/s12640-012-9334-7.","journal-title":"Neurotox Res"},{"key":"1098_CR22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/jnen\/nlz084","volume":"78","author":"M Moretti","year":"2019","unstructured":"Moretti M, Belli G, Morini L, Monti MC, Osculati AMM, Visona SD. Drug abuse-related neuroinflammation in human postmortem brains: an immunohistochemical approach. J Neuropathol Exp Neurol. 2019;78:1059\u201365. https:\/\/doi.org\/10.1093\/jnen\/nlz084.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1098_CR23","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25:1822\u201332. https:\/\/doi.org\/10.1038\/s41591-019-0675-0.","journal-title":"Nat Med"},{"key":"1098_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/ijms18030651","volume":"18","author":"H Barron","year":"2017","unstructured":"Barron H, Hafizi S, Andreazza AC, Mizrahi R. Neuroinflammation and oxidative stress in psychosis and psychosis risk. Int J Mol Sci. 2017;18:651. https:\/\/doi.org\/10.3390\/ijms18030651.","journal-title":"Int J Mol Sci"},{"key":"1098_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/can.2018.0073","volume":"5","author":"JM Nichols","year":"2020","unstructured":"Nichols JM, Kaplan BLF. Immune responses regulated by cannabidiol. Cannabis Cannabinoid Res. 2020;5:12\u201331. https:\/\/doi.org\/10.1089\/can.2018.0073.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1098_CR26","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1111\/bph.15208","volume":"177","author":"M McKenna","year":"2020","unstructured":"McKenna M, McDougall JJ. Cannabinoid control of neurogenic inflammation. Br J Pharmacol. 2020;177:4386\u201399. https:\/\/doi.org\/10.1111\/bph.15208.","journal-title":"Br J Pharmacol"},{"key":"1098_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox9010021","volume":"9","author":"S Atalay","year":"2019","unstructured":"Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants. 2019;9:21. https:\/\/doi.org\/10.3390\/antiox9010021.","journal-title":"Antioxidants"},{"key":"1098_CR28","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s40265-018-0992-5","volume":"78","author":"S Lattanzi","year":"2018","unstructured":"Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, et al. Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis. Drugs 2018;78:1791\u2013804. https:\/\/doi.org\/10.1007\/s40265-018-0992-5.","journal-title":"Drugs"},{"key":"1098_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuro.2019.08.002","volume":"74","author":"S Bonaccorso","year":"2019","unstructured":"Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F, Cannabidiol CBD. use in psychiatric disorders: a systematic review. Neurotoxicology 2019;74:282\u201398. https:\/\/doi.org\/10.1016\/j.neuro.2019.08.002.","journal-title":"Neurotoxicology"},{"key":"1098_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.14740\/jocmr4090","volume":"12","author":"C Larsen","year":"2020","unstructured":"Larsen C, Shahinas J. Dosage, efficacy and safety of cannabidiol administration in adults: a systematic review of human trials. J Clin Med Res. 2020;12:129\u201341. https:\/\/doi.org\/10.14740\/jocmr4090.","journal-title":"J Clin Med Res"},{"key":"1098_CR31","doi-asserted-by":"publisher","first-page":"e00682","DOI":"10.1002\/prp2.682","volume":"8","author":"DL de Almeida","year":"2020","unstructured":"de Almeida DL, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharm Res Perspect. 2020;8:e00682. https:\/\/doi.org\/10.1002\/prp2.682.","journal-title":"Pharm Res Perspect"},{"key":"1098_CR32","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dc16-0650","volume":"39","author":"KA Jadoon","year":"2016","unstructured":"Jadoon KA, Ratcliffe SH, Barrett DA, Thomas EL, Stott C, Bell JD, et al. Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. Diabetes Care. 2016;39:1777\u201386. https:\/\/doi.org\/10.2337\/dc16-0650.","journal-title":"Diabetes Care"},{"key":"1098_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/add.15417","author":"V Mongeau-Perusse","year":"2021","unstructured":"Mongeau-Perusse V, Brissette S, Bruneau J, Conrod P, Dubreucq S, Gazil G, et al. Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a Randomized Placebo-Controlled Trial. Addiction 2021. https:\/\/doi.org\/10.1111\/add.15417.","journal-title":"Addiction"},{"key":"1098_CR34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00213-005-0303-1","volume":"185","author":"HC Fox","year":"2006","unstructured":"Fox HC, Garcia M Jr, Kemp K, Milivojevic V, Kreek MJ, Sinha R. Gender differences in cardiovascular and corticoadrenal response to stress and drug cues in cocaine dependent individuals. Psychopharmacology. 2006;185:348\u201357. https:\/\/doi.org\/10.1007\/s00213-005-0303-1.","journal-title":"Psychopharmacology"},{"key":"1098_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.addbeh.2003.08.029","volume":"29","author":"CP Ferri","year":"2004","unstructured":"Ferri CP, Dunn J, Gossop M, Laranjeira R. Factors associated with adverse reactions to cocaine among a sample of long-term, high-dose users in Sao Paulo, Brazil. Addict Behav. 2004;29:365\u201374. https:\/\/doi.org\/10.1016\/j.addbeh.2003.08.029.","journal-title":"Addict Behav"},{"key":"1098_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","volume":"2","author":"K Iffland","year":"2017","unstructured":"Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis Cannabinoid Res. 2017;2:139\u201354. https:\/\/doi.org\/10.1089\/can.2016.0034.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1098_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-801284-0.00001-4","volume":"118","author":"C Cui","year":"2014","unstructured":"Cui C, Shurtleff D, Harris RA. Neuroimmune mechanisms of alcohol and drug addiction. Int Rev Neurobiol. 2014;118:1\u201312. https:\/\/doi.org\/10.1016\/B978-0-12-801284-0.00001-4.","journal-title":"Int Rev Neurobiol"},{"key":"1098_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1684\/ecn.2020.0445","volume":"31","author":"Y Szekely","year":"2020","unstructured":"Szekely Y, Ingbir M, Bentur OS, Hochner O, Porat R. Natural cannabinoids suppress the cytokine storm in sepsis-like in vitro model. Eur Cytokine Netw. 2020;31:50\u20138. https:\/\/doi.org\/10.1684\/ecn.2020.0445.","journal-title":"Eur Cytokine Netw"},{"key":"1098_CR39","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0109","author":"DJ Yeisley","year":"2021","unstructured":"Yeisley DJ, Arabiyat AS, Hahn MS. Cannabidiol-driven alterations to inflammatory protein landscape of lipopolysaccharide-activated macrophages in vitro may be mediated by autophagy and oxidative stress. Cannabis Cannabinoid Res. 2021. https:\/\/doi.org\/10.1089\/can.2020.0109.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1098_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02892-1","volume":"11","author":"T Lowin","year":"2020","unstructured":"Lowin T, Tingting R, Zurmahr J, Classen T, Schneider M, Pongratz G. Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death Dis. 2020;11:714. https:\/\/doi.org\/10.1038\/s41419-020-02892-1.","journal-title":"Cell Death Dis"},{"key":"1098_CR41","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1098_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2353\/ajpath.2006.050500","volume":"168","author":"AB El-Remessy","year":"2006","unstructured":"El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol. 2006;168:235\u201344. https:\/\/doi.org\/10.2353\/ajpath.2006.050500.","journal-title":"Am J Pathol"},{"key":"1098_CR43","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/1947601912466556","volume":"3","author":"Y Maor","year":"2012","unstructured":"Maor Y, Yu J, Kuzontkoski PM, Dezube BJ, Zhang X, Groopman JE. Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium. Genes Cancer. 2012;3:512\u201320. https:\/\/doi.org\/10.1177\/1947601912466556.","journal-title":"Genes Cancer"},{"key":"1098_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature03987","volume":"437","author":"SM Weis","year":"2005","unstructured":"Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005;437:497\u2013504. https:\/\/doi.org\/10.1038\/nature03987.","journal-title":"Nature"},{"key":"1098_CR45","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1172\/JCI60842","volume":"122","author":"AT Argaw","year":"2012","unstructured":"Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, et al. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest. 2012;122:2454\u201368. https:\/\/doi.org\/10.1172\/JCI60842.","journal-title":"J Clin Invest"},{"key":"1098_CR46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s0301-0082(02)00128-4","volume":"68","author":"MA Petty","year":"2002","unstructured":"Petty MA, Lo EH. Junctional complexes of the blood\u2013brain barrier: permeability changes in neuroinflammation. Prog Neurobiol. 2002;68:311\u201323. https:\/\/doi.org\/10.1016\/s0301-0082(02)00128-4.","journal-title":"Prog Neurobiol"},{"key":"1098_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fncel.2016.00002","volume":"10","author":"Y Suzuki","year":"2016","unstructured":"Suzuki Y, Nagai N, Umemura K. A review of the mechanisms of blood\u2013brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia. Front Cell Neurosci. 2016;10:2 https:\/\/doi.org\/10.3389\/fncel.2016.00002.","journal-title":"Front Cell Neurosci"},{"key":"1098_CR48","doi-asserted-by":"publisher","first-page":"117906951879363","DOI":"10.1177\/1179069518793639","volume":"12","author":"DI Lurie","year":"2018","unstructured":"Lurie DI. An integrative approach to neuroinflammation in psychiatric disorders and neuropathic pain. J Exp Neurosci. 2018;12:1179069518793639. https:\/\/doi.org\/10.1177\/1179069518793639.","journal-title":"J Exp Neurosci"},{"key":"1098_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1017\/S1092852918001499","volume":"24","author":"C Fourrier","year":"2019","unstructured":"Fourrier C, Singhal G, Baune BT. Neuroinflammation and cognition across psychiatric conditions. CNS Spectr. 2019;24:4\u201315. https:\/\/doi.org\/10.1017\/S1092852918001499.","journal-title":"CNS Spectr"},{"key":"1098_CR50","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep. 2016;13:3391\u20136. https:\/\/doi.org\/10.3892\/mmr.2016.4948.","journal-title":"Mol Med Rep"},{"key":"1098_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/mmr.2016.5974","volume":"15","author":"HT Zhang","year":"2017","unstructured":"Zhang HT, Zhang P, Gao Y, Li CL, Wang HJ, Chen LC, et al. Early VEGF inhibition attenuates blood\u2013brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep. 2017;15:57\u201364. https:\/\/doi.org\/10.3892\/mmr.2016.5974.","journal-title":"Mol Med Rep"},{"key":"1098_CR52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.expneurol.2006.11.001","volume":"204","author":"OZ Chi","year":"2007","unstructured":"Chi OZ, Hunter C, Liu X, Weiss HR. Effects of anti-VEGF antibody on blood\u2013brain barrier disruption in focal cerebral ischemia. Exp Neurol. 2007;204:283\u20137. https:\/\/doi.org\/10.1016\/j.expneurol.2006.11.001.","journal-title":"Exp Neurol"},{"key":"1098_CR53","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2018.06.023","volume":"124","author":"HY Wu","year":"2018","unstructured":"Wu HY, Huang CH, Lin YH, Wang CC, Jan TR. Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production. Free Radic Biol Med. 2018;124:311\u20138. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.023.","journal-title":"Free Radic Biol Med"},{"key":"1098_CR54","doi-asserted-by":"publisher","first-page":"H610","DOI":"10.1152\/ajpheart.00236.2007","volume":"293","author":"M Rajesh","year":"2007","unstructured":"Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, Drel VR, et al. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol. 2007;293:H610\u20139. https:\/\/doi.org\/10.1152\/ajpheart.00236.2007.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1098_CR55","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.1800742","volume":"203","author":"AD Dhanda","year":"2019","unstructured":"Dhanda AD, Williams EL, Yates E, Lait PJP, Schewitz-Bowers LP, Hegazy D, et al. Intermediate monocytes in acute alcoholic hepatitis are functionally activated and induce IL-17 expression in CD4(+) T cells. J Immunol. 2019;203:3190\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1800742.","journal-title":"J Immunol"},{"key":"1098_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/cei.12880","volume":"187","author":"P Gaur","year":"2017","unstructured":"Gaur P, Myles A, Misra R, Aggarwal A. Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis. Clin Exp Immunol. 2017;187:234\u201341. https:\/\/doi.org\/10.1111\/cei.12880.","journal-title":"Clin Exp Immunol"},{"key":"1098_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/srep11888","volume":"5","author":"EC O\u2019Brien","year":"2015","unstructured":"O\u2019Brien EC, Abdulahad WH, Rutgers A, Huitema MG, O\u2019Reilly VP, Coughlan AM, et al. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1beta secretion in response to anti-MPO antibodies. Sci Rep. 2015;5:11888. https:\/\/doi.org\/10.1038\/srep11888.","journal-title":"Sci Rep"},{"key":"1098_CR58","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1042\/CS20170009","volume":"131","author":"CN Franca","year":"2017","unstructured":"Franca CN, Izar MCO, Hortencio MNS, do Amaral JB, Ferreira CES, Tuleta ID, et al. Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease. Clin Sci. 2017;131:1215\u201324. https:\/\/doi.org\/10.1042\/CS20170009.","journal-title":"Clin Sci"},{"key":"1098_CR59","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3389\/fimmu.2019.01642","volume":"10","author":"AA Wolf","year":"2019","unstructured":"Wolf AA, Yanez A, Barman PK, Goodridge HS. The ontogeny of monocyte subsets. Front Immunol. 2019;10:1642 https:\/\/doi.org\/10.3389\/fimmu.2019.01642.","journal-title":"Front Immunol"},{"issue":"Suppl 3","key":"1098_CR60","first-page":"99","volume":"60","author":"B Ignatowska-Jankowska","year":"2009","unstructured":"Ignatowska-Jankowska B, Jankowski M, Glac W, Swiergel AH. Cannabidiol-induced lymphopenia does not involve NKT and NK cells. J Physiol Pharmacol. 2009;60 Suppl 3:99\u2013103.","journal-title":"J Physiol Pharmacol"},{"key":"1098_CR61","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.intimp.2007.01.015","volume":"7","author":"TR Jan","year":"2007","unstructured":"Jan TR, Su ST, Wu HY, Liao MH. Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB\/c mice. Int Immunopharmacol. 2007;7:773\u201380. https:\/\/doi.org\/10.1016\/j.intimp.2007.01.015.","journal-title":"Int Immunopharmacol"},{"key":"1098_CR62","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.taap.2007.09.012","volume":"226","author":"HY Wu","year":"2008","unstructured":"Wu HY, Chu RM, Wang CC, Lee CY, Lin SH, Jan TR. Cannabidiol-induced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8. Toxicol Appl Pharmacol. 2008;226:260\u201370. https:\/\/doi.org\/10.1016\/j.taap.2007.09.012.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1098_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cellimm.2016.11.006","volume":"312","author":"S Dhital","year":"2017","unstructured":"Dhital S, Stokes JV, Park N, Seo KS, Kaplan BL. Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation. Cell Immunol. 2017;312:25\u201334. https:\/\/doi.org\/10.1016\/j.cellimm.2016.11.006.","journal-title":"Cell Immunol"},{"key":"1098_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.phrp.2014.04.008","volume":"5","author":"A Bahador","year":"2014","unstructured":"Bahador A, Hadjati J, Hassannejad N, Ghazanfari H, Maracy M, Jafari S, et al. Frequencies of CD4+ T regulatory cells and their CD25(high) and FoxP3(high) subsets augment in peripheral blood of patients with acute and chronic Brucellosis. Osong Public Health Res Perspect. 2014;5:161\u20138. https:\/\/doi.org\/10.1016\/j.phrp.2014.04.008.","journal-title":"Osong Public Health Res Perspect"},{"key":"1098_CR65","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00262-015-1729-x","volume":"64","author":"SJ Santegoets","year":"2015","unstructured":"Santegoets SJ, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, et al. Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry. Cancer Immunol Immunother. 2015;64:1271\u201386. https:\/\/doi.org\/10.1007\/s00262-015-1729-x.","journal-title":"Cancer Immunol Immunother"},{"key":"1098_CR66","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nri821","volume":"2","author":"EM Shevach","year":"2002","unstructured":"Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002;2:389\u2013400. https:\/\/doi.org\/10.1038\/nri821.","journal-title":"Nat Rev Immunol"},{"key":"1098_CR67","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","volume":"70","author":"A Corthay","year":"2009","unstructured":"Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70:326\u201336. https:\/\/doi.org\/10.1111\/j.1365-3083.2009.02308.x.","journal-title":"Scand J Immunol"},{"key":"1098_CR68","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3389\/fimmu.2018.01625","volume":"9","author":"M Romano","year":"2018","unstructured":"Romano M, Fanelli G, Tan N, Nova-Lamperti E, McGregor R, Lechler RI, et al. Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells. Front Immunol. 2018;9:1625. https:\/\/doi.org\/10.3389\/fimmu.2018.01625.","journal-title":"Front Immunol"},{"key":"1098_CR69","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fimmu.2019.00714","volume":"10","author":"N Guo","year":"2019","unstructured":"Guo N, Liu L, Yang X, Song T, Li G, Li L, et al. Immunological changes in monocyte subsets and their association with Foxp3(+) regulatory T cells in HIV-1-infected individuals with syphilis: a brief research report. Front Immunol. 2019;10:714. https:\/\/doi.org\/10.3389\/fimmu.2019.00714.","journal-title":"Front Immunol"},{"key":"1098_CR70","doi-asserted-by":"publisher","first-page":"724","DOI":"10.18632\/aging.101774","volume":"11","author":"B Muller-Durovic","year":"2019","unstructured":"Muller-Durovic B, Grahlert J, Devine OP, Akbar AN, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging. 2019;11:724\u201340. https:\/\/doi.org\/10.18632\/aging.101774.","journal-title":"Aging"},{"key":"1098_CR71","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","volume":"10","author":"O Melaiu","year":"2019","unstructured":"Melaiu O, Lucarini V, Cifaldi L, Fruci D. Influence of the tumor microenvironment on NK cell function in solid tumors. Front Immunol. 2019;10:3038. https:\/\/doi.org\/10.3389\/fimmu.2019.03038.","journal-title":"Front Immunol"},{"key":"1098_CR72","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","volume":"34","author":"B Chan","year":"2019","unstructured":"Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, Kansagara D. Pharmacotherapy for cocaine use disorder\u2014a systematic review and meta-analysis. J Gen Intern Med. 2019;34:2858\u201373. https:\/\/doi.org\/10.1007\/s11606-019-05074-8.","journal-title":"J Gen Intern Med"},{"key":"1098_CR73","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/npp.2015.367","volume":"41","author":"M Haney","year":"2016","unstructured":"Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, et al. Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis. Neuropsychopharmacology 2016;41:1974\u201382. https:\/\/doi.org\/10.1038\/npp.2015.367.","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-01098-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-01098-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-01098-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T19:59:06Z","timestamp":1633982346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-01098-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1038\/s41386-021-01098-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740564073.793589343","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"assertion":[{"value":"12 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"VM-P, ER, PT, SL, SB, SD, ES, and J-FC declare no competing interests. The funders of the study and Insys Therapeutics had no role in study design, data collection, data analysis, data interpretation, writing of the report, or decision to publish.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}